Research

- 4DX

- IPO to raise $55.8M

- 76.42M shares @ $0.73

- MC $193M

- Primary market US$19.7B spent on respiratory diagnostics across 73.5M procedures 2019

- Secondary market AUS$404M across 5.3M procedures.

- FDA approval receivedMay 2020 to use the technology in its ventilation analysis software

- TGA anticipatedapproval next year 2021

- Already have grantedand pending patents in AUS, EUR and ASIA

- Funds used formarketing, operating expenditure, product research and development, sales and distributionin the US, clinical trials, trade shows

- Commercialise lungimaging technology in the US

- Develop patented X-rayimaging platform that scans patients respiratory system to help improve theability of physicians to diagnose and manage lung diseases

- XV Technology platformdelivery via cloud-based SaaS (lower cost option and it doesn’t require capitalexpenditure to be compatible with existing hospital and clinical equipment)

- Aims to supplement orreplace existing respiratory diagnostic systems

- Planning to conduct 10clinical trials in the US

- XV Technology can bedeployed immediately, using the existing hospital and clinical infrastructurewith no capital expenditure or training required, the company noted.

- The process requiresimaging departments to electronically send an X-ray, which is taken usingexisting fluoroscopy equipment, to 4DMedical.

- Dr. Andreas Fouras (MDand CEO)

- 2012 founded

- Board:

o Bruce Rathie (non-exec of PNV and NET)

o Dr Robert Figlin (former CEO LBT and founding partner of IDX)

o More here https://4dmedical.com/team/

Trade shows looking to attend:

- American ThoracicSociety annual conference - May 14-19, 2021

- American College ofChest Physicians annual meeting - October 18-21

- Radiological Society ofNorth America meeting - Nov. 29 toDec. 5

https://4dmedical.com/

https://**promotion blocked**.com.au/4dmedical-asx-ipo-commercialise-lung-imaging-technology-united-states/

https://kalkinemedia.com/au/news/ipo/asx-welcomes-healthcare-player-medtech-firm-4dmedical-rolled-out-ipo-two-weeks-earlier

https://**promotion blocked**/ipo-watch/another-medtech-stock-is-about-to-hit-the-asx-block-and-its-already-got-fda-approval/

https://www.medicaldevice-network.com/news/us-fda-4dmedical-lung-imaging-technology/

http://fda.einnews.com/article/517874244?lcf=DHhUJxYYvCspG0nkwrpma6-uTQdcDx1sPgpesTXntx0%3D